文献
J-GLOBAL ID:201702263390652287
整理番号:17A1493028
リンゴ試験:実現可能性とEGFR変異NSCLC患者における正PLasma T790MのAZD9291(Osimertinib)治療の活性EORTC1613【Powered by NICT】
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613
著者 (13件):
Remon Jordi
(Department of Oncology Medicine, Gustave Roussy, Universite Paris-Saclay, Villejuif, France)
,
Menis Jessica
(European Organisation for Research and Treatment of Cancer, Brussels, Belgium)
,
Hasan Baktiar
(European Organisation for Research and Treatment of Cancer, Brussels, Belgium)
,
Peric Aleksandra
(European Organisation for Research and Treatment of Cancer, Brussels, Belgium)
,
De Maio Eleonora
(European Organisation for Research and Treatment of Cancer, Brussels, Belgium)
,
Novello Silvia
(Oncology Department, University of Turin, AOU San Luigi-Orbassano, Orbassano, Italy)
,
Reck Martin
(Lung Clinic Grosshansdorf, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany)
,
Berghmans Thierry
(Department of Intensive Care and Oncological Emergencies & Thoracic Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium)
,
Wasag Bartosz
(Department of Biology and Genetics, Medical University of Gdansk, Gdansk, Poland)
,
Wasag Bartosz
(Laboratory of Clinical Genetics, University Clinical Centre, Gdansk, Poland)
,
Besse Benjamin
(European Organisation for Research and Treatment of Cancer, Brussels, Belgium)
,
Besse Benjamin
(University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France)
,
Dziadziuszko Rafal
(Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland)
資料名:
Clinical Lung Cancer
(Clinical Lung Cancer)
巻:
18
号:
5
ページ:
583-588
発行年:
2017年
JST資料番号:
W3210A
ISSN:
1525-7304
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)